{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:17Z","timestamp":1785412517598,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,13]]},"DOI":"10.7759\/cureus.84033","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:42:02Z","timestamp":1747154522000},"source":"Crossref","is-referenced-by-count":1,"title":["Exacerbation of Intracranial and Gastrointestinal Bleeding in Patients Above 50 Years of Age Co-treated With Antidepressants and Anticoagulants\/Platelet Inhibitors at a Lebanese University Hospital"],"prefix":"10.7759","author":[{"given":"Khalil","family":"Richa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"El Batrouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Sarkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Aad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Kassab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna N","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2016.03.012","article-title":"[The pharmacological basis of the serotonin system: application to antidepressant response]","volume":"42","author":"David DJ","year":"2016","unstructured":"David DJ, Gardier AM. [The pharmacological basis of the serotonin system: application to antidepressant response]. Encephale. 2016, 42:255-63. 10.1016\/j.encep.2016.03.012","journal-title":"Encephale"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi AS","year":"2004","unstructured":"Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004, 28:435-51. 10.1016\/j.pnpbp.2003.11.018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199810060-00005","article-title":"Selective serotonin reuptake inhibitor-induced disturbances of haemostasis: mechanisms and therapeutic implications","volume":"10","author":"Berk M","year":"1998","unstructured":"Berk M, Jacobson BF. Selective serotonin reuptake inhibitor-induced disturbances of haemostasis: mechanisms and therapeutic implications. CNS Drugs. 1998, 10:441-6. 10.2165\/00023210-199810060-00005","journal-title":"CNS Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin D","year":"2007","unstructured":"Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007, 9:47-59. 10.31887\/DCNS.2007.9.1\/dhalperin","journal-title":"Dialogues Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte S","year":"2017","unstructured":"Laporte S, Chapelle C, Caillet P, et al.. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res. 2017, 118:19-32. 10.1016\/j.phrs.2016.08.017","journal-title":"Pharmacol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.06.021","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis","volume":"13","author":"Jiang HY","year":"2015","unstructured":"Jiang HY, Chen HZ, Hu XJ, et al.. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015, 13:42-50.e3. 10.1016\/j.cgh.2014.06.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4529","article-title":"Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage","volume":"74","author":"Renoux C","year":"2017","unstructured":"Renoux C, Vahey S, Dell'Aniello S, Boivin JF. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. 2017, 74:173-80. 10.1001\/jamaneurol.2016.4529","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S45445","article-title":"The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports","volume":"5","author":"Perahia DG","year":"2013","unstructured":"Perahia DG, Bangs ME, Zhang Q, et al.. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthc Patient Saf. 2013, 5:211-9. 10.2147\/DHPS.S45445","journal-title":"Drug Healthc Patient Saf"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.048","article-title":"Intracranial hemorrhage during dual antiplatelet therapy: JACC review topic of the week","volume":"78","author":"Ha AC","year":"2021","unstructured":"Ha AC, Bhatt DL, Rutka JT, Johnston SC, Mazer CD, Verma S. Intracranial hemorrhage during dual antiplatelet therapy: JACC review topic of the week. J Am Coll Cardiol. 2021, 78:1372-84. 10.1016\/j.jacc.2021.07.048","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v4.i1.40","article-title":"Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy","volume":"4","author":"Yasuda H","year":"2015","unstructured":"Yasuda H, Matsuo Y, Sato Y, et al.. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med. 2015, 4:40-6. 10.5492\/wjccm.v4.i1.40","journal-title":"World J Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2020.01.001","article-title":"Anticoagulant-associated intracerebral hemorrhage","volume":"1","author":"Morotti A","year":"2020","unstructured":"Morotti A, Goldstein JN. Anticoagulant-associated intracerebral hemorrhage. Brain Hemorrhages. 2020, 1:89-94. 10.1016\/j.hest.2020.01.001","journal-title":"Brain Hemorrhages"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1730035","article-title":"Gastrointestinal bleeding and direct oral anticoagulants among patients with atrial fibrillation: risk, prevention, management, and quality of life","volume":"5","author":"Zappulla P","year":"2021","unstructured":"Zappulla P, Calvi V. Gastrointestinal bleeding and direct oral anticoagulants among patients with atrial fibrillation: risk, prevention, management, and quality of life. TH Open. 2021, 5:e200-10. 10.1055\/s-0041-1730035","journal-title":"TH Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2019.02.006","article-title":"Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes","volume":"16","author":"De Rosa R","year":"2019","unstructured":"De Rosa R, Piscione F, Galasso G, De Servi S, Savonitto S. Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes. J Geriatr Cardiol. 2019, 16:103-13. 10.11909\/j.issn.1671-5411.2019.02.006","journal-title":"J Geriatr Cardiol"},{"key":"ref14","article-title":"Geriatric depression: the use of antidepressants in the elderly","volume":"53","author":"Wiese BS","year":"2011","unstructured":"Wiese BS. Geriatric depression: the use of antidepressants in the elderly. BC Med J. 2011, 53:341-7.","journal-title":"BC Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s4308","article-title":"Use of anticoagulants in elderly patients: practical recommendations","volume":"4","author":"Robert-Ebadi H","year":"2009","unstructured":"Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging. 2009, 4:165-77. 10.2147\/cia.s4308","journal-title":"Clin Interv Aging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/070674371105600702","article-title":"Psychiatric disorders in the elderly","volume":"56","author":"Skoog I","year":"2011","unstructured":"Skoog I. Psychiatric disorders in the elderly. Can J Psychiatry. 2011, 56:387-97. 10.1177\/070674371105600702","journal-title":"Can J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0013-7006(10)70018-X","article-title":"[Mental health of elderly people: the prevalence and representations of psychiatric disorders] (Article in French)","volume":"36","author":"Giordana JY","year":"2010","unstructured":"Giordana JY, Roelandt JL, Porteaux C. [Mental health of elderly people: the prevalence and representations of psychiatric disorders] (Article in French). Encephale. 2010, 36:59-64. 10.1016\/S0013-7006(10)70018-X","journal-title":"Encephale"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1268-8","article-title":"Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR","volume":"68","author":"Maschino F","year":"2012","unstructured":"Maschino F, Hurault-Delarue C, Chebbane L, Fabry V, Montastruc JL, Bagheri H. Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR. Eur J Clin Pharmacol. 2012, 68:1557-60. 10.1007\/s00228-012-1268-8","journal-title":"Eur J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.2017474","article-title":"Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis","volume":"54","author":"Nochaiwong S","year":"2022","unstructured":"Nochaiwong S, Ruengorn C, Awiphan R, et al.. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022, 54:80-97. 10.1080\/07853890.2021.2017474","journal-title":"Ann Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03634.x","article-title":"A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia","volume":"52","author":"Webert KE","year":"2012","unstructured":"Webert KE, Arnold DM, Lui Y, Carruthers J, Arnold E, Heddle NM. A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia. Transfusion. 2012, 52:2466-74. 10.1111\/j.1537-2995.2012.03634.x","journal-title":"Transfusion"},{"key":"ref21","unstructured":"Agence nationale de securite du medicament et des produits de sante. Th\u00e9saurus des interactions m\u00e9dicamenteuses. (2020). Accessed: 2022: https:\/\/ansm.sante.fr\/documents\/reference\/thesaurus-des-interactions-medicamenteuses-1."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.100912","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos C","year":"2011","unstructured":"Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011, 183:1835-43. 10.1503\/cmaj.100912","journal-title":"CMAJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-021-00258-3","article-title":"Association of type of antidepressant initiation with bleeding risk in atrial fibrillation patients taking oral anticoagulants","volume":"8","author":"Shao IY","year":"2021","unstructured":"Shao IY, Claxton JS, Lutsey PL, Chen LY, MacLehose RF, Alonso A. Association of type of antidepressant initiation with bleeding risk in atrial fibrillation patients taking oral anticoagulants. Drugs Real World Outcomes. 2021, 8:383-91. 10.1007\/s40801-021-00258-3","journal-title":"Drugs Real World Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081240","article-title":"Patients with heart failure and preserved ejection fraction are at risk of gastrointestinal bleeding","volume":"8","author":"Schrutka L","year":"2019","unstructured":"Schrutka L, Seirer B, Duca F, et al.. Patients with heart failure and preserved ejection fraction are at risk of gastrointestinal bleeding. J Clin Med. 2019, 8:10.3390\/jcm8081240","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.016022","article-title":"Risk of stroke in patients with heart failure: a population-based 30-year cohort study","volume":"48","author":"Adelborg K","year":"2017","unstructured":"Adelborg K, Sz\u00e9pligeti S, Sundb\u00f8ll J, et al.. Risk of stroke in patients with heart failure: a population-based 30-year cohort study. Stroke. 2017, 48:1161-8. 10.1161\/STROKEAHA.116.016022","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001245","article-title":"ACG clinical guideline: upper gastrointestinal and ulcer bleeding","volume":"116","author":"Laine L","year":"2021","unstructured":"Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol. 2021, 116:899-917. 10.14309\/ajg.0000000000001245","journal-title":"Am J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.41","article-title":"ACG clinical guideline: management of patients with acute lower gastrointestinal bleeding","volume":"111","author":"Strate LL","year":"2016","unstructured":"Strate LL, Gralnek IM. ACG clinical guideline: management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol. 2016, 111:459-74. 10.1038\/ajg.2016.41","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251363-exacerbation-of-intracranial-and-gastrointestinal-bleeding-in-patients-above-50-years-of-age-co-treated-with-antidepressants-and-anticoagulantsplatelet-inhibitors-at-a-lebanese-university-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:42:07Z","timestamp":1747154527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251363-exacerbation-of-intracranial-and-gastrointestinal-bleeding-in-patients-above-50-years-of-age-co-treated-with-antidepressants-and-anticoagulantsplatelet-inhibitors-at-a-lebanese-university-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}